Next Article in Journal
Erinacenones M–Y, Part 2: Thirteen New Isoindolinone Alkaloids with α-Glucosidase Inhibitory Activity from Liquid Cultures of the Edible and Medicinal Mushroom Hericium erinaceus
Previous Article in Journal
DFT Investigation of 4-Mercaptoimidazole–Copper(I/II) Redox Chemistry and C2-Substituent Effects: A Minimal Scaffold Study of Ovothiol-Type Redox Cycling
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 31
Issue 18
10.3390/molecules31183332
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite
Correction to Molecules 2023, 28(4), 1576.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Taya et al. Clinical Evaluation Based on a New Approach to Improve the Accuracy of 4β-Hydroxycholesterol Measurement as a Biomarker of CYP3A4 Activity. Molecules 2023, 28, 1576

by
Yuki Taya
1,2,
Mari Mizunaga
2,
Shunsuke Nakao
2,
Mirinthorn Jutanom
1,
Naoki Shimizu
1,
Yukihiro Nomura
2 and
Kiyotaka Nakagawa
1,*
1
Laboratory of Food Function Analysis, Graduate School of Agricultural Science, Tohoku University, Sendai 980-8572, Miyagi, Japan
2
Drug Metabolism and Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc., Takatsuki 569-1125, Osaka, Japan
*
Author to whom correspondence should be addressed.
Molecules 2026, 31(18), 3332; https://doi.org/10.3390/molecules31183332 (registering DOI)
Submission received: 14 September 2026 / Accepted: 16 September 2026 / Published: 20 September 2026
Versions Notes
In the original publication [1], the Conflicts of Interest statement was inaccurate. The correct Conflicts of Interest is as follows:
Conflicts of Interest: Yuki Taya, Mari Mizunaga, Shunsuke Nakao, and Yukihiro Nomura are employees of Japan Tobacco, Inc. Yuki Taya is also affiliated with Tohoku University for degree purposes. The authors declare that this study received funding from Akros Pharma, Inc., Princeton, NJ, USA. Akros Pharma, Inc. is a subsidiary of Japan Tobacco, Inc. Japan Tobacco, Inc. provided financial support for the conduct of the study. However, Japan Tobacco, Inc. was not involved in the study design, data collection, analysis, interpretation, writing of the manuscript, or the decision to submit it for publication.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Taya, Y.; Mizunaga, M.; Nakao, S.; Jutanom, M.; Shimizu, N.; Nomura, Y.; Nakagawa, K. Clinical Evaluation Based on a New Approach to Improve the Accuracy of 4β-Hydroxycholesterol Measurement as a Biomarker of CYP3A4 Activity. Molecules 2023, 28, 1576. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Taya, Y.; Mizunaga, M.; Nakao, S.; Jutanom, M.; Shimizu, N.; Nomura, Y.; Nakagawa, K. Correction: Taya et al. Clinical Evaluation Based on a New Approach to Improve the Accuracy of 4β-Hydroxycholesterol Measurement as a Biomarker of CYP3A4 Activity. Molecules 2023, 28, 1576. Molecules 2026, 31, 3332. https://doi.org/10.3390/molecules31183332

AMA Style

Taya Y, Mizunaga M, Nakao S, Jutanom M, Shimizu N, Nomura Y, Nakagawa K. Correction: Taya et al. Clinical Evaluation Based on a New Approach to Improve the Accuracy of 4β-Hydroxycholesterol Measurement as a Biomarker of CYP3A4 Activity. Molecules 2023, 28, 1576. Molecules. 2026; 31(18):3332. https://doi.org/10.3390/molecules31183332

Chicago/Turabian Style

Taya, Yuki, Mari Mizunaga, Shunsuke Nakao, Mirinthorn Jutanom, Naoki Shimizu, Yukihiro Nomura, and Kiyotaka Nakagawa. 2026. "Correction: Taya et al. Clinical Evaluation Based on a New Approach to Improve the Accuracy of 4β-Hydroxycholesterol Measurement as a Biomarker of CYP3A4 Activity. Molecules 2023, 28, 1576" Molecules 31, no. 18: 3332. https://doi.org/10.3390/molecules31183332

APA Style

Taya, Y., Mizunaga, M., Nakao, S., Jutanom, M., Shimizu, N., Nomura, Y., & Nakagawa, K. (2026). Correction: Taya et al. Clinical Evaluation Based on a New Approach to Improve the Accuracy of 4β-Hydroxycholesterol Measurement as a Biomarker of CYP3A4 Activity. Molecules 2023, 28, 1576. Molecules, 31(18), 3332. https://doi.org/10.3390/molecules31183332

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop